MDEV
First Trust Indxx Medical Devices ETF
MDEV tracks an equal-weighted index that gives global exposure to the medical equipment industry.
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 3.4 M
ASSETS UNDER MGMT
70 bp
EXPENSES
Fund Basics
| Inception date | Jun 22, 2021 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| GE HEALTHCARE TECHNOLOGIES INC. | 2.2 % |
| KONINKLIIJKE ELECTRONICS NV | 2.2 % |
| COCHLEAR LIMITED | 2.2 % |
| COLOPLAST A/S CLASS B | 2.2 % |
| ALCON, INC. | 2.2 % |
| SIEMENS HEALTHINEERS AG | 2.2 % |
| BIOMERIEUX SA | 2.2 % |
| WEST PHARMACEUTICAL SERVICES | 2.2 % |
| CARL ZEISS MEDITEC AG | 2.2 % |
| TELEFLEX INC | 2.2 % |
Constituent Breakdown
| Number of holdings | 54 |
| Herfindahl-Hirschman Index | 203 |
| Wgt avg mkt cap (mns) | $37,881 |
| Large cap (>$10bn) | 77.5% |
| Mid cap ($2-10bn) | 19.9% |
| Small cap (<$2bn) | 1.9% |
| Developed mkts. | 96.2% |
| Emerging mkts. | 3.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 54.5 % |
 |
JAPAN | 7.6 % |
 |
SWITZERLAND | 6.5 % |
 |
GERMANY | 4.4 % |
 |
DENMARK | 4.3 % |
 |
FRANCE | 4.3 % |
 |
IRELAND | 4.1 % |
 |
BRITAIN | 4.1 % |
 |
CHINA | 3.0 % |
 |
NETHERLANDS | 2.2 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -1.0% | 4.0% | -3.4% | 4.8% | -4.4% | -- | -- | -3.7% |
| Dividend Yield | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | -- | -- | 0.0% |
| Total Returns | -0.9% | 4.1% | -3.4% | 4.8% | -4.3% | -- | -- | -3.6% | Ann. Volatility | 17.2% | 16.5% | 17.4% | 16.7% | 19.2% | -- | -- | 18.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.61 | 23% |
| MSCI EAFE | 0.56 | 29% |
| MSCI Emg Mkts | 0.18 | 8% |
Liquidity Measures
| Avg. volume (000) | 2 |
| ADV traded (mns) | $0 |
| Turnover | 1.3% |
| Avg. Bid/Ask (% of price) | 0.19% |
Technical Indicators
| 30d moving avg. (EMA) | $21.45 |
| Relative strength (RSI) | 61 |
| MACD/Signal | 0.33/0.31 |
| Bollinger Bands (Upper/Lower) | $22.56/$20.56 |
| Short interest (% of AUM) | 4.4% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. MDEV |
Expenses vs. MDEV |
ALTAR Score™ vs. MDEV |
|---|---|---|---|---|
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 38.2% | -30 bp | +1.6% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 35.9% | -35 bp | -3.4% |
| IHI | iShares U.S. Medical Devices ETF | 31.5% | -33 bp | 0.0% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 30.0% | +10 bp | -3.4% |
| FXH | First Trust Health Care AlphaDEX Fund | 22.7% | -9 bp | +0.6% |
| AGNG | Global X Aging Population ETF | 21.0% | -20 bp | -0.1% |
| XLV | Health Care Select Sector SPDR | 19.2% | -62 bp | +1.3% |
| IYH | iShares U.S. Healthcare ETF | 19.0% | -33 bp | +0.7% |
| IXJ | iShares Global Healthcare ETF | 18.6% | -32 bp | +1.1% |
| VHT | Vanguard Health Care ETF | 18.3% | -61 bp | +0.1% |
Risk and Returns: MDEV vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
4.7%
ALTAR SCORE™
48th
PERCENTILE
NEUTRAL
ETFRC RATING
There are 746 funds in the Global Equity category with an average
ALTAR Score™ of 4.8% and a standard deviation
of 2.6%. MDEV's ALTAR Score™ is approximately -0.1 standard
deviations above the category average. This places MDEV in the 48th percentile
among funds in the category.
Sell-Side Consensus
$24.91
PRICE TARGET
+8.4%
UPSIDE